๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Antibody specificity and immunoglobulin VH utilization of human monoclonal CD5+ B cell lines

โœ Scribed by Mieke E. M. Schutte; Saskia B. Ebeling; Karine E. Akkermans; Frits H. J. Gmelig-Meyling; Ton Logtenberg

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
751 KB
Volume
21
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A monoclonal antibody with anti-burkitt
A monoclonal antibody with anti-burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines
โœ J. Wiels; G. M. Lenoir; M. Fellous; M. Lipinski; J. C. Salomon; C. Tetaud; T. Tu ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 634 KB

## Abstract 38โ€13 is a hybridomaโ€produced monoclonal rat IgM which appears to define a Burkitt's lymphomaโ€associated antigen (BLA). In this paper, we describe the reactivity of 38โ€13 with a panel of human haematopoietic and lymphoid cell lines. In indirect immunofluorescence (IF) assays, 15 of 26 B

Chimeric, divalent and tetravalent anti-
Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines
โœ Xiao-Yun Liu; Laurentiu M. Pop; Lydia Tsai; Iliodora V. Pop; Ellen S. Vitetta ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 295 KB

## Abstract CD19 is an attractive therapeutic target for treating human Bโ€cell tumors. In our study, chimeric (c) divalent (cHD37) and tetravalent (cHD37โ€DcVV) antiโ€CD19 monoclonal antibodies (MAbs) were constructed, expressed and evaluated for their binding to human 19โ€positive (CD19^+^) tumor cel